(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PEMAZYRE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PEMAZYRE

ST13

US500000088616570

Class

5

Filing

88616570

Registration

6494001

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

08/01/2026

Trademark type

Combined

Nice classes

5

Filing date

09/13/2019

Registration date

09/21/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/21/2021

Last transaction

08/01/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2021-02-00

First use in commerce

2021-02-00

Drawing code

3

Owner type

03

Owner location

Wilmington, DE, US

Examiner

BILLINGS, JOHN T

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "PEMAZYRE" followed by three overlapping triangles with their common point above an elliptical disc.

Holders and representatives

Holders

INCYTE HOLDINGS CORPORATION

Representatives

Keith Toms, Esq. McCarter & English, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders

Publications

History of USPTO decisions and trademark events.

40 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

07/31/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/31/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/31/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/31/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/31/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/31/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

09/21/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/20/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/19/2021

EEXT

SOU TEAS EXTENSION RECEIVED

08/05/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/20/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/16/2021

IUAF

USE AMENDMENT FILED

07/07/2021

EISU

TEAS STATEMENT OF USE RECEIVED

07/07/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/05/2021

EX1G

SOU EXTENSION 1 GRANTED

02/03/2021

EXT1

SOU EXTENSION 1 FILED

02/03/2021

EEXT

SOU TEAS EXTENSION RECEIVED

02/03/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/11/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/16/2020

PUBO

PUBLISHED FOR OPPOSITION

06/16/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/27/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/08/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/18/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/17/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/17/2020

ALIE

ASSIGNED TO LIE

04/16/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/11/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/11/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/11/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/11/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/11/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/11/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/16/2019

GNRT

NON-FINAL ACTION E-MAILED

12/16/2019

CNRT

NON-FINAL ACTION WRITTEN

12/16/2019

DOCK

ASSIGNED TO EXAMINER

12/13/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/24/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/23/2019

NWAP

NEW APPLICATION ENTERED

09/17/2019

Continuous trademark protection

Get notified about every new filing that threatens PEMAZYRE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.